A healthier future is possible with AAGP®
See the life changing potential
If you could help find treatments for blindness, heart disease, stroke and Type 1 diabetes, what would that be worth to you? With AAGP®, we can get closer to affordable, accessible treatments for the conditions that affect our lives. But we need your support to continue exploring the potential. See our greatest areas of opportunity.
By regenerating retinal cells in humans and animals, AAGP® has the potential to treat millions suffering from dry eyes and blindness.
As many as 12 million Americans are living with vision impairment.
Compared to preventative skincare products that need to be applied before environmental exposure, AAGP® can recover skin cells after the damage is done, as demonstrated in a laboratory setting.
More than 85 million people are affected by skin conditions in the U.S. each year.
During today’s transplants, organs can only survive around four hours. With AAGP®, we hope to extend their viability to 24 hours.
About 80 people receive transplants each day.
In the realm of cell therapy and cancer immunotherapy, AAGP® could be the link to essential advancements.
Over 1 million people have been treated by cell therapies worldwide.
Since 2005, AAGP® has gone through international laboratory testing conducted by some of the top researchers in the world. See their scientific contributions.
Invest with us
Become part of the next great medical discovery. ProtoKinetix has harnessed a molecule found in nature with the power to change lives through cell survival.
Join us on our journey of cell survival
Get company news and research updates sent directly to your inbox.